Parathyroid Hormone

Parathyroid hormone (PTH) is produced by four small glands located behind the thyroid gland in your neck. These glands constantly monitor the level of calcium in your blood and release PTH when calcium levels drop below the optimal range. PTH acts on three main organs — bones, kidneys, and the intestines — to restore balance. In the bones, PTH signals the release of stored calcium into the bloodstream; in the kidneys, it reduces calcium loss through urine and activates vitamin D into its active form, calcitriol; and in the intestines, calcitriol enhances calcium absorption from food.

This hormone’s activity is tightly linked with vitamin D and phosphorus. Vitamin D deficiency, kidney dysfunction, or dietary imbalances can all interfere with this finely tuned system. Optimal PTH levels therefore reflect not only healthy parathyroid gland function but also sufficient calcium, magnesium, and vitamin D intake — all essential for proper nerve transmission, muscle contraction, and bone remodeling.

PTH plays a vital role in bone and mineral metabolism, influencing nearly every process that depends on calcium. Calcium is more than just a bone mineral — it’s a signalling molecule required for muscle movement, nerve communication, hormone secretion, and blood clotting. When calcium levels fall, PTH is released to bring them back to normal by:

• Mobilising calcium from bones, ensuring short-term availability when dietary intake is insufficient.

• Enhancing calcium absorption from the intestines by stimulating vitamin D activation.

• Conserving calcium in the kidneys, reducing urinary excretion.
  

However, sustained imbalances can cause serious health issues:

• High PTH (hyperparathyroidism) leads to excessive calcium release from bones, weakening them over time and increasing the risk of osteoporosis, fractures, and kidney stones. It may also raise calcium levels in the blood (hypercalceamia), leading to fatigue, muscle weakness, and mood changes.
  

• Low PTH (hypoparathyroidism) results in low calcium levels (hypocalceamia) and symptoms such as muscle cramps, tingling, numbness, and in severe cases, cardiac arrhythmias.
  

• Long-term PTH dysregulation also affects cardiovascular health, as both calcium excess and deficiency influence vascular tone and blood pressure regulation.
  

Healthy PTH levels support strong bones, balanced electrolytes, and optimal nerve and muscle function. They also depend on the interplay of other biomarkers, including vitamin D, phosphorus, magnesium, and kidney function indicators, which should always be assessed together for accurate interpretation.

PTH levels are sensitive to nutrient status, lifestyle factors, and metabolic conditions that affect calcium and vitamin D balance.

Dietary Factors:
Diets high in phosphorus (found in soft drinks, processed meats, and fast foods) can elevate PTH by lowering calcium absorption. Conversely, adequate calcium intake from dairy, leafy greens, sardines, or fortified plant milks helps maintain healthy PTH levels. Vitamin D-rich foods such as fatty fish (salmon, mackerel, sardines) and egg yolks enhance calcium absorption and lower PTH when it’s elevated.

Lifestyle Factors:
Lack of sunlight, physical inactivity, and chronic stress can disrupt vitamin D activation and calcium metabolism, causing PTH to rise. Weight-bearing exercise helps maintain bone density, improving calcium utilisation and reducing the need for excess PTH secretion.

Related Biomarkers:
PTH interacts closely with vitamin D, calcium, phosphorus, and magnesium. Low vitamin D or calcium typically raises PTH, while high calcium suppresses it. Kidney function tests (creatinine, eGFR) are also important because impaired kidneys reduce vitamin D activation and increase PTH levels.

Micronutrient Impacts:
Deficiencies in vitamin D, magnesium, or calcium can all raise PTH. Magnesium is particularly important, as it supports both parathyroid gland function and vitamin D metabolism.

Environmental Influences:
Chronic stress, sleep deprivation, and certain medications (like loop diuretics or corticosteroids) may alter calcium and PTH regulation.

If Your Results Are High

Elevated PTH suggests your body is trying to compensate for low calcium or vitamin D, or that the parathyroid glands are overactive.

Diet:
Focus on restoring calcium and vitamin D balance. Include 2–3 servings of calcium-rich foods daily such as yogurt, cheese, fortified nut milks, or leafy greens. Eat vitamin D-rich foods like fatty fish, eggs, and mushrooms exposed to UV light. Limit high-phosphorus foods such as processed meats, cola drinks, and fast food.

Lifestyle:

• Spend 10–20 minutes in sunlight daily to boost natural vitamin D production.

• Engage in weight-bearing exercise (walking, strength training) to maintain bone strength.

• Practice stress-reduction techniques (yoga, mindfulness) to regulate adrenal hormones that may impact calcium metabolism.

Supplements:

• If dietary intake is low, a calcium supplement (500–1,000 mg/day) and vitamin D3 (1,000–2,000 IU/day) may be considered under medical supervision.

• Magnesium (200–400 mg/day) can further support calcium regulation.

If Your Results Are Low

Low PTH indicates reduced parathyroid activity or high calcium levels suppressing PTH secretion.

Diet:
Ensure adequate calcium intake through dairy products, sardines, almonds, tahini, and leafy greens. Include vitamin D-rich foods and moderate protein intake to support calcium absorption. Avoid excessive calcium supplementation unless prescribed, as this can further suppress PTH.

Lifestyle:

• Maintain regular physical activity to support bone turnover.

• Avoid very high sodium intake, which increases urinary calcium loss.

• Focus on balanced hydration and adequate sleep to reduce stress-related calcium imbalance.

Supplements:

• Consider vitamin D3 if levels are low (under professional guidance).

• If hypocalceamia symptoms occur, calcium citrate may be prescribed.

• Magnesium supports parathyroid function and should be optimised through food sources (pumpkin seeds, spinach, avocado).

1. Silva BC, Cusano NE, Bilezikian JP. Primary Hyperparathyroidism. Best Practice & Research Clinical Endocrinology & Metabolism. 2024;38(1):101247. https://doi.org/10.1016/j.beem.2018.09.013
   
   

2. Milat F, Ramchand SK, Herath M, et al. Primary Hyperparathyroidism in Adults—(Part I) Assessment and Medical Management: Position Statement of the Endocrine Society of Australia, the Australian & New Zealand Endocrine Surgeons, and the Australian & New Zealand Bone and Mineral Society. Clinical Endocrinology. 2024;100(1):3–18. https://doi.org/10.1111/cen.14659
   
   

3. Marcocci C, Cetani F. Clinical Practice: Primary Hyperparathyroidism.New England Journal of Medicine. 2011;365(25):2389–2397. https://doi.org/10.1056/NEJMcp1106636